SCHEMBL22922484

SCHEMBL22922484

Cc1cc(-c2cnc3[nH]cc(-c4ccc(C(=O)N(C)C[C@@H]5CCOC5)cc4)c3c2)cc2c1N1CCN(C)C[C@@H]1CC2

nearest known ligand 0.77

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 6/20 0.77
PIK3CG P48736 6/20 0.43
MAP3K11 Q16584 2/20 0.42
TNIK Q9UKE5 4/20 0.41
CYP11B2 P19099 1/20 0.38
DYRK1B Q9Y463 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29869055 1.00 MAP4K1 (0.77) MAP4K1PIK3CGMAP3K11TNIKCYP11B2
SCHEMBL22922393 1.00 MAP4K1 (0.77) MAP4K1PIK3CGMAP3K11TNIKCYP11B2
SCHEMBL29869247 1.00 MAP4K1 (0.77) MAP4K1PIK3CGMAP3K11TNIKCYP11B2
SCHEMBL29869145 1.00 MAP4K1 (0.77) MAP4K1PIK3CGMAP3K11TNIKCYP11B2
SCHEMBL22922488 1.00 MAP4K1 (0.77) MAP4K1PIK3CGMAP3K11TNIKCYP11B2
SCHEMBL29869158 1.00 MAP4K1 (0.77) MAP4K1PIK3CGMAP3K11TNIKCYP11B2
SCHEMBL22922392 1.00 MAP4K1 (0.77) MAP4K1PIK3CGMAP3K11TNIKCYP11B2
SCHEMBL22922395 0.89 MAP4K1 (0.61) MAP4K1PIK3CGMAP3K11CYP11B2
SCHEMBL22922396 0.89 MAP4K1 (0.61) MAP4K1PIK3CGMAP3K11CYP11B2
SCHEMBL29869239 0.89 MAP4K1 (0.61) MAP4K1PIK3CGMAP3K11CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112239473-B Process for preparing tricyclic compounds as HPK1 inhibitors 百济神州(北京)生物科技有限公司 2023-12-08 CN disclosed
CN-114127067-A Tricyclic compounds as HPK1 inhibitors and uses thereof 百济神州有限公司 2022-03-01 CN disclosed
WO-2021013083-A1 TRICYCLIC COMPOUNDS AS HPK1 INHIBITOR AND THE USE THEREOF BEIGENE, LTD. (KY) 2021-01-28 WO disclosed
CN-112239473-A Tricyclic compounds as HPK1 inhibitors 百济神州(北京)生物科技有限公司 2021-01-19 CN disclosed